investment

News

Jazz breaks ground on $100m UK plant for cannabinoid drugs

Jazz Pharma has started construction of a manufacturing facility in the UK that will be used to manufacture cannabinoid drugs from its recently

News

NHS said to be central to Moderna interest in UK facility

Moderna is reportedly in late-stage negotiations with the UK government that could result in a new research and manufacturing facility being set up in the biotech 'golden triangle' between

News

Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.

Otsuka dips its toe in psychedelic waters, backing Mindset P...

Despite the growing interest in developing medicines based on psychedelic compounds, big pharma has seemed a bit wary of getting involved, leaving the task to small start-ups.

Views & Analysis

When biotech meets reality TV - Starton Therapeutics faces t...

Starton Therapeutics is bypassing the traditional venture capital route to raise money for its transdermal delivery technology that delivers medicine through the skin.

R&D

The Alderley Park Discovery Podcast: The journey to accessin...

Episode 3 of the Alderley Park Discovery Podcast covers how to successfully access life science funding and investment, highlighting a range of ways companies can attract investors.

News